Superparamagnetic iron oxide nanoparticles: Diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review

Journal of Cerebral Blood Flow and Metabolism

Volumn 30, Issue 1, 2010, Pages 15-35

  Weinstein, Jason S ^a   Varallyay, Csanad G ^a,b   Dosa, Edit ^a   Gahramanov, Seymur ^a   Hamilton, Bronwyn ^a   Rooney, William D ^c   Muldoon, Leslie L ^a   Neuwelt, Edward A ^a,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; CNS tumors; Magnetic resonance imaging; Ultrasmall superparamagnetic iron oxide nanoparticles

Indexed keywords

FERUCARBOTRAN; FERUMOXYTOL; GADOTERIDOL; N ACETYLCOLCHINOL PHOSPHATE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VANDETANIB; VSOP C 184;

ANTIANGIOGENIC THERAPY; BLOOD BRAIN BARRIER; BRAIN CANCER; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG BRAIN LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SYNTHESIS; EPILEPSY; GLIOBLASTOMA; HOT FLUSH; HUMAN; HYPOTENSION; IRON OVERLOAD; MEDICAL TECHNOLOGY; MOLECULAR IMAGING; MULTIPLE SCLEROSIS; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; PROLACTINOMA; PRURITUS; REVIEW; RISK BENEFIT ANALYSIS; STROKE;

ANIMALS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM NEOPLASMS; CONTRAST MEDIA; ELECTRON SPIN RESONANCE SPECTROSCOPY; FERRIC COMPOUNDS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; PARTICLE SIZE;

EID: 73949137249     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2009.192     Document Type: Review

References (126)

1. Akeson P, Nordstrom CH, Holtas S (1997) Time-dependency in brain lesion enhancement with gadodiamide injection. Acta Radiol 38:19-24
2. Akhtari M, Bragin A, Cohen M, Moats R, Brenker F, Lynch MD, Vinters HV, Engel Jr J (2008) Functionalized magnetonanoparticles for MRI diagnosis and localization in epilepsy. Epilepsia 49:1419-1430
3. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA (2004a) Efficient magnetic cell labeling with protamine sulfate com-plexed to ferumoxides for cellular MRI. Blood 104:1217-1223
4. Arbab AS, Yocum GT, Wilson LB, Parwana A, Jordan EK, Kalish H, Frank JA (2004b) Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 3:24-32
5. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH et al. (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51
6. Audebert HJ, Rott MM, Eck T, Haberl RL (2004) Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35:2128-2133
7. Baeten K, Hendriks JJ, Hellings N, Theunissen E, Vander-locht J, Ryck LD, Gelan J, Stinissen P, Adriaensens P (2008) Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encepha-lomyelitis by magnetic resonance imaging. J Neuroim-munol 195:1-6
8. Banks WA (1999) Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. J Neu-rovirol 5:538-555
9. Bareyre FM (2008) Neuronal repair and replacement in spinal cord injury. J Neurol Sci 265:63-72
10. Barnett PA, Roman-Goldstein S, Ramsey F, McCormick CI, Sexton G, Szumowski J, Neuwelt EA (1995) Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat. Am J Pathol 146:436-449
11. Bendszus M, Bartsch A, Stoll G (2005) Is the disruption of the blood-brain barrier a prerequisite for cellular infiltration in autoimmune encephalitis? Brain 128:E25
12. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123(Pt 6):1174-1183
13. Blockley NP, Jiang L, Gardener AG, Ludman CN, Francis ST, Gowland PA (2008) Field strength dependence of R1 and R2* relaxivities of human whole blood to ProHance, Vasovist, and deoxyhemoglobin. Magn Reson Med 60:1313-1320
14. Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee JM, Jacobs PM, Lewis JM (2006) Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultra-small superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 41:313-324
15. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453-461
16. Brekke C, Williams SC, Price J, Thorsen F, Modo M (2007) Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model. Neuroimage 37:769-782
17. Brochet B, Deloire MS, Touil T, Anne O, Caille JM, Dousset V, Petry KG (2006) Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE. Neuroimage 32:266-274
18. Cameron DG, Bensley EH, Wood P, Grayston V (1951) Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route. Can Med Assoc J 64:27-30
19. Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken R, Ross BD, Chenevert TL, Lawrence TS (2006) Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys 64:876-885
20. Cappendijk VC, Kessels AG, Heeneman S, Cleutjens KB, Schurink GW, Welten RJ, Mess WH, van Suylen RJ, Leiner T, Daemen MJ, van Engelshoven JM, Kooi ME (2008) Comparison of lipid-rich necrotic core size in symptomatic and asymptomatic carotid atherosclerotic plaque: initial results. J Magn Reson Imaging 27: 1356-1361
21. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfu-sion MR imaging. Radiology 223:11-29
22. Chang KH, Ra DG, Han MH, Cha SH, Kim HD, Han MC (1994) Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T. AJNR Am J Neuroradiol 15:1413-9; discussion 1420-11413
23. Chenevert TL, Pipe JG, Williams DM, Brunberg JA (1991) Quantitative measurement of tissue perfusion and diffusion in vivo. Magn Reson Med 17:197-212
24. Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC (2008) Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29:487-496
25. Claes A, Gambarota G, Hamans B, van Tellingen O, Wesseling P, Maass C, Heerschap A, Leenders W (2008) Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. Int J Cancer 122:1981-1986
26. Corot C, Petry KG, Trivedi R, Saleh A, Jonkmanns C, Le Bas JF, Blezer E, Rausch M, Brochet B, Foster-Gareau P, Baleriaux D, Gaillard S, Dousset V (2004) Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamag-netic iron oxide in magnetic resonance imaging. Invest Radiol 39:619-625
27. Corot C, Robert P, Idee JM, Port M (2006) Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58:1471-1504
28. Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S, Rosenbrock H, Keller U, Heinzmann U, Rummeny EJ, Schlegel J, Link TM (2003) Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228:760-767
29. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95-112
30. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA, Allan SM (2007) Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab 27:1941-1953
31. Donahue KM, Krouwer HG, Rand SD, Pathak AP, Marszalk-owski CS, Censky SC, Prost RW (2000) Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 43:845-853
32. Dousset V, Brochet B, Deloire MS, Lagoarde L, Barroso B, Caille JM, Petry KG (2006) MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol 27:1000-1005
33. Enochs WS, Harsh G, Hochberg F, Weissleder R (1999) Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging 9:228-232
34. Essig M, Weber MA, von Tengg-Kobligk H, Knopp MV, Yuh WT, Giesel FL (2006) Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications. Top Magn Reson Imaging 17:89-106
35. Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer C (2001) Magnetic labeling of activated micro-glia in experimental gliomas. Neoplasia 3:489-499
36. Floris S, Blezer EL, Schreibelt G, Dopp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE (2004) Blood-brain barrier permeability and mono-cyte infiltration in experimental allergic encephalomye-litis: a quantitative MRI study. Brain 127:616-627
37. Gore JC, Majumdar S (1990) Measurement of tissue blood flow using intravascular relaxation agents and magnetic resonance imaging. Magn Reson Med 14:242-248
38. Groothuis DR, Vriesendorp FJ, Kupfer B, Warnke PC, Lapin GD, Kuruvilla A, Vick NA, Mikhael MA, Patlak CS (1991) Quantitative measurements of capillary transport in human brain tumors by computed tomography. Ann Neurol 30:581-588
39. Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H (1993) Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28(Suppl 1):S28-43
40. Hartman KB, Wilson LJ, Rosenblum MG (2008) Detecting and treating cancer with nanotechnology. Mol Diagn Ther 12:1-14
41. Henning EC, Ruetzler CA, Gaudinski MR, Hu TC, Latour LL, Hallenbeck JM, Warach S (2009) Feridex preloading permits tracking of CNS-resident macrophages after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 29:1229-1239
42. Herschman HR (2003) Molecular imaging: looking at problems, seeing solutions. Science 302:605-608
43. Hoehn M, Wiedermann D, Justicia C, Ramos-Cabrer P, Kruttwig K, Farr T, Himmelreich U (2007) Cell tracking using magnetic resonance imaging. J Physiol 584:25-30
44. Hunt MA, Bago AG, Neuwelt EA (2005) Single-dose contrast agent for intraoperative MR imaging of intrinsic brain tumors by using ferumoxtran-10. AJNR Am J Neuroradiol 26:1084-1088
45. Idiyatullin D, Corum C, Park JY, Garwood M (2006) Fast and quiet MRI using a swept radiofrequency. J Magn Reson 181:342-349
46. Jander S, Schroeter M, Saleh A (2007) Imaging inflammation in acute brain ischemia. Stroke 38:642-645
47. Juhasz C, Chugani DC, Padhye UN, Muzik O, Shah A, Asano E, Mangner TJ, Chakraborty PK, Sood S, Chugani HT (2004) Evaluation with alpha-[11C]methyl-L- trypto-phan positron emission tomography for reoperation after failed epilepsy surgery. Epilepsia 45:124-130
48. Ke Y, Ming Qian Z (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2:246-253
49. Khoo VS, Joon DL (2006) New developments in MRI for target volume delineation in radiotherapy. Br J Radiol 79(Spec No 1):S2-15
50. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791-798
51. Korosoglou G, Tang L, Kedziorek D, Cosby K, Gilson WD, Vonken EJ, Schar M, Sosnovik D, Kraitchman DL, Weiss RG Weissleder R Stuber M 2008 Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON) J Magn Reson Imaging 27, 1175-1180
52. Ra G, Weissleder R, Stuber M (2008) Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON). J Magn Reson Imaging 27:1175-1180
53. Kraemer DF, Fortin D, Doolittle ND, Neuwelt EA (2001) Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (human non-acquired immunodeficiency syndrome) and survival. Neurosurgery 48:1033-40; discussion 1040-11031
54. Kremer S, Grand S, Remy C, Esteve F, Lefournier V, Pasquier B, Hoffmann D, Benabid AL, Le Bas JF (2002) Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 29:105-113
55. Kremer S, Pinel S, Vedrine PO, Bressenot A, Robert P, Bracard S, Plenat F (2007) Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation? J Neurooncol 83:111-119
56. Kroll RA, Neuwelt EA (1998) Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42:1083-99; discussion 1099-1100
57. Kulbatski I, Mothe AJ, Nomura H, Tator CH (2005) Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma. Curr Drug Targets 6:111-126
58. Landry R, Jacobs PM, Davis R, Shenouda M, Bolton WK (2005) Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients. Am J Nephrol 25:400-410
59. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064-2110
60. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR, IV, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas (corrected). AJNR Am J Neuroradiol 25:214-221
61. Long DM (1979) Capillary ultrastructure in human meta-static brain tumors. J Neurosurg 51:53-58
62. Lyons SA, O0Neal J, Sontheimer H (2002) Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia 39:162-173
63. Macdonald DR, Cascino TL, Schold Jr SC, Cairncross JG (1990) Response criteria for phase II studies of supra-tentorial malignant glioma. J Clin Oncol 8:1277-1280
64. Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, Jordan A (2007) Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 81:53-60
65. Manninger SP, Muldoon LL, Nesbit G, Murillo T, Jacobs PM, Neuwelt EA (2005) An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. AJNR Am J Neuroradiol 26: 2290-2300
66. Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, Poremba C, Ebert W, Heindel W, Bremer C (2005) Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 235:155-161
67. McAteer MA, Sibson NR, von Zur Muhlen C, Schneider JE, Lowe, Warrick N, Channon KM, Anthony DC, Choudh-ury RP (2007) In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med 13:1253-1258
68. McDonald RP, Horsburgh KJ, Graham DI, Nicoll JA (1999) Mitochondrial DNA deletions in acute brain injury. Neuroreport 10:1875-1878
69. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE (2004) Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 14:1851-1858
70. Miki Y, Grossman RI, Udupa JK, Samarasekera S, van Buchem MA, Cooney BS, Pollack SN, Kolson DL, Constantinescu C, Polansky M, Mannon LJ (1997) Computer-assisted quantitation of enhancing lesions in multiple sclerosis: correlation with clinical classification. AJNR Am J Neuroradiol 18:705-710 (Pubitemid 27175968)
71. Miki Y, Grossman RI, Udupa JK, van Buchem MA, Wei L, Phillips MD, Patel U, McGowan JC, Kolson DL (1999) Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging. Radiology 210:769-774
72. Modo M, Hoehn M, Bulte JW (2005) Cellular MR imaging. Mol Imaging 4:143-164
73. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, Norman D (1990) Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 11:423-429
74. Mulder WJ, Douma K, Koning GA, van Zandvoort MA, Lutgens E, Daemen MJ, Nicolay K, Strijkers GJ (2006) Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse. Magn Reson Med 55:1170-1174
75. Muldoon LL, Sandor M, Pinkston KE, Neuwelt EA (2005) Imaging, distribution, and toxicity of superparamag-netic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 57:785-96; discussion 785-796
76. Muldoon LL, Tratnyek PG, Jacobs PM, Doolittle ND, Christoforidis GA, Frank JA, Lindau M, Lockman PR, Manninger SP, Qiang Y, Spence AM, Stupp SI, Zhang M, Neuwelt EA (2006) Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting. AJNR Am J Neuror-adiol 27:715-721
77. Muldoon LL, Varallyay P, Kraemer DF, Kiwic G, Pinkston K, Walker-Rosenfeld SL, Neuwelt EA (2004) Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat. Neuropathol Appl Neurobiol 30:70-79
78. Neuwelt EA, Hamilton BE, Varallyay CG, Rooney WR, Edelman RD, Jacobs PM, Watnick SG (2008) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int 75:465-474
79. Neuwelt EA, Varallyay CG, Manninger S, Solymosi D, Haluska M, Hunt MA, Nesbit G, Stevens A, Jerosch-Herold M, Jacobs PM, Hoffman JM (2007) The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study. Neurosurgery 60:601-11; discussion 611-1602
80. Neuwelt EA, Varallyay P, Bago AG, Muldoon LL, Nesbit G, Nixon R (2004) Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol 30:456-471
81. Neuwelt EA, Weissleder R, Nilaver G, Kroll RA, Roman-Goldstein S, Szumowski J, Pagel MA, Jones RS, Remsen LG, McCormick CI et al. (1994) Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosur-gery 34:777-784
82. Nighoghossian N, Wiart M, Cakmak S, Berthezene Y, Derex L, Cho TH, Nemoz C, Chapuis F, Tisserand GL, Pialat JB, Trouillas P, Froment JC, Hermier M (2007) Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients. Stroke 38:303-307 (Pubitemid 46184299)
83. Oh J, Henry RG, Pirzkall A, Lu Y, Li X, Catalaa I, Chang S, Dillon WP, Nelson SJ (2004) Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 19:546-554
84. Ostergaard L (2005) Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging 22:710-717 (Pubitemid 41741235)
85. Oude Engberink RD, van der Pol SM, Dopp EA, de Vries HE, Blezer EL (2007) Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 243:467-474
86. Rausch M, Hiestand P, Baumann D, Cannet C, Rudin M (2003) MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med 50:309-314
87. Rausch M, Hiestand P, Foster CA, Baumann DR, Cannet C, Rudin M (2004) Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 20:16-24
88. Rausch M, Sauter A, Frohlich J, Neubacher U, Radu EW, Rudin M (2001) Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med 46:1018-1022
89. Robinson SP, Howe FA, Griffiths JR, Ryan AJ, Waterton JC (2007) Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126. Int J Radiat Oncol Biol Phys 69:872-879
90. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715-724
91. Rooney WD, Johnson G, Li X, Cohen ER, Kim SG, Ugurbil K, Springer Jr CS (2007) Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med 57:308-318
92. Ros PR, Freeny PC, Harms SE, Seltzer SE, Davis PL, Chan TW, Stillman AE, Muroff LR, Runge VM, Nissenbaum MA et al. (1995) Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196:481-488
93. Rose SE, Janke AL, Strudwick MW, McMahon KL, Chalk JB, Snyder P, De zubicaray GI (2006) Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: a human pharmacological magnetic resonance imaging study at 1.5 and 4 T. Magn Reson Med 55:9-15
94. Rosen BR, Belliveau JW, Vevea JM, Brady TJ (1990) Perfusion imaging with NMR contrast agents. Magn Reson Med 14:249-265
95. Ruehm SG, Corot C, Vogt P, Cristina H, Debatin JF (2002) Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits. Acad Radiol 9(Suppl 1): S143-4
96. Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW (2008) In vivo 'hot spot' MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med 60:1506-1511
97. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, Modder U, Jander S (2004a) In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127:1670-1677
98. Saleh A, Schroeter M, Ringelstein A, Hartung HP, Siebler M, Modder U, Jander S (2007) Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke. Stroke 38:2733-2737
99. Saleh A, Wiedermann D, Schroeter M, Jonkmanns C, Jander S, Hoehn M (2004b) Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imaging. NMR Biomed 17:163-169
100. Schaefer PW, Barak ER, Kamalian S, Gharai LR, Schwamm L, Gonzalez RG, Lev MH (2008) Quantitative assessment of core/penumbra mismatch in acute stroke. CT and MR perfusion imaging are strongly correlated when sufficient brain volume is imaged. Stroke 39:2986-2992
101. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R (2003) Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183:25-33
102. Schroeter M, Franke C, Stoll G, Hoehn M (2001) Dynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brain. Acta Neuropathol 101:114-122
103. Schroeter M, Jander S, Huitinga I, Witte OW, Stoll G (1997) Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia. Stroke 28:382-386
104. Soroceanu L, Gillespie Y, Khazaeli MB, Sontheimer H (1998) Use of chlorotoxin for targeting of primary brain tumors. Cancer Res 58:4871-4879
105. Spinowitz BS, Schwenk MH, Jacobs PM, Bolton WK, Kaplan MR, Charytan C, Galler M (2005) The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients. Kidney Int 68:1801-1807
106. Stoll G, Jander S, Schroeter M (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neuro-biol 56:149-171
107. Stroke (1989) Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke 20:1407-1431
108. Stuber M, Gilson WD, Schar M, Kedziorek DA, Hofmann LV, Shah S, Vonken EJ, Bulte JW, Kraitchman DL (2007) Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med 58:1072-1077
109. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479-1486
110. Sykova E, Jendelova P (2007) In vivo tracking of stem cells in brain and spinal cord injury. Prog Brain Res 161:367-383
111. Tanaka R, Komine-Kobayashi M, Mochizuki H, Yamada M, Furuya T, Migita M, Shimada T, Mizuno Y, Urabe T (2003) Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience 117:531-539
112. Tang T, Howarth SP, Miller SR, Trivedi R, Graves MJ, King-Im JU, Li ZY, Brown AP, Kirkpatrick PJ, Gaunt ME, Gillard JH (2006) Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 37:2266-2270
113. Thorek DL, Chen AK, Czupryna J, Tsourkas A (2006) Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34:23-38
114. Uematsu H, Maeda M (2006) Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability. Eur Radiol 16:180-186
115. van Landeghem FK, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow U, Scholz R, Thiesen B, Bruck W, von Deimling A (2009) Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30:52-57
116. Varallyay CG, Muldoon LL, Gahramanov S, Wu YJ, Goodman JA, Li X, Pike MM, Neuwelt EA (2009) Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model. J Cereb Blood Flow Metab 29:853-860
117. Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, Cohen JI, Petrillo A, Rink D, Neuwelt EA (2002) Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 23:510-519
118. Vellinga MM, Oude Engberink RD, Seewann A, Pouwels PJ, Wattjes MP, van der Pol SM, Pering C, Polman CH, de Vries HE, Geurts JJ, Barkhof F (2008) Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131:800-807
119. Verdijk P, Scheenen TW, Lesterhuis WJ, Gambarota G, Veltien AA, Walczak P, Scharenborg NM, Bulte JW, Punt CJ, Heerschap A, Figdor CG, de Vries IJ (2007) Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer 120:978-984
120. Villringer A, Rosen BR, Belliveau JW, Ackerman JL, Lauffer RB, Buxton RB, Chao YS, Wedeen VJ, Brady TJ (1988) Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 6:164-174
121. Weber R, Ramos-Cabrer P, Hoehn M (2006) Present status of magnetic resonance imaging and spectroscopy in animal stroke models. J Cereb Blood Flow Metab 26: 591-604
122. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L (1990) Ultrasmall superpar-amagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175:489-493
123. Willmore LJ, Sypert GW, Munson JB (1978) Recurrent seizures induced by cortical iron injection: a model of posttraumatic epilepsy. Ann Neurol 4:329-336
124. Wu X, Hu J, Zhou L, Mao Y, Yang B, Gao L, Xie R, Xu F, Zhang D, Liu J, Zhu J (2008) In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled me-senchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation. J Neurosurg 108:320-329
125. Wu YJ, Muldoon LL, Varallyay C, Markwardt S, Jones RE, Neuwelt EA (2007) In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging. Am J Physiol Cell Physiol 293:C1698-708
126. Yuh WT, Crain MR, Loes DJ, Greene GM, Ryals TJ, Sato Y (1991) MR imaging of cerebral ischemia: findings in the first 24 hours. AJNR Am J Neuroradiol 12:621-629